Signetti, L.; Elizarov, N.; Simsir, M.; Paquet, A.; Douguet, D.; Labbal, F.; Debayle, D.; Di Giorgio, A.; Biou, V.; Girard, C.;
et al. Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma. Cancers 2020, 12, 1500.
https://doi.org/10.3390/cancers12061500
AMA Style
Signetti L, Elizarov N, Simsir M, Paquet A, Douguet D, Labbal F, Debayle D, Di Giorgio A, Biou V, Girard C,
et al. Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma. Cancers. 2020; 12(6):1500.
https://doi.org/10.3390/cancers12061500
Chicago/Turabian Style
Signetti, Laurie, Nelli Elizarov, Méliné Simsir, Agnès Paquet, Dominique Douguet, Fabien Labbal, Delphine Debayle, Audrey Di Giorgio, Valérie Biou, Christophe Girard,
and et al. 2020. "Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma" Cancers 12, no. 6: 1500.
https://doi.org/10.3390/cancers12061500
APA Style
Signetti, L., Elizarov, N., Simsir, M., Paquet, A., Douguet, D., Labbal, F., Debayle, D., Di Giorgio, A., Biou, V., Girard, C., Duca, M., Bretillon, L., Bertolotto, C., Verrier, B., Azoulay, S., & Mus-Veteau, I.
(2020). Inhibition of Patched Drug Efflux Increases Vemurafenib Effectiveness against Resistant BrafV600E Melanoma. Cancers, 12(6), 1500.
https://doi.org/10.3390/cancers12061500